Poor sleep is a hallmark of Alzheimer's disease. People with the disease tend to wake up tired, and their nights become even less refreshing as memory loss and other symptoms worsen. But how and why restless nights are linked ...
Jan 9, 2019
0
1442
Pancreatic cancer is especially challenging to treat—only eight percent of patients are still alive five years after diagnosis. Chemotherapy and radiation therapy are of limited benefit, and even immunotherapy—which revolutionized ...
Jul 3, 2019
0
9
Scientists potentially have found a way to disrupt Zika and similar viruses from spreading in the body.
Jun 17, 2016
0
512
It may be possible in the future to screen patients for Alzheimer's disease using an eye exam.
Aug 23, 2018
0
349
There's not much good that can be said about asthma, a breathing disease in which the airways become narrowed and inflamed. But there's this: People with asthma seem to be less likely to develop brain tumors than others. ...
Dec 10, 2021
0
150
Signaling a potential new approach to treating diabetes, researchers at Washington University School of Medicine in St. Louis and Harvard University have produced insulin-secreting cells from stem cells derived from patients ...
May 10, 2016
0
272
Infections and neurodegenerative diseases cause inflammation in the brain. But for unknown reasons, patients with brain inflammation often develop muscle problems that seem to be independent of the central nervous system. ...
Jul 12, 2024
0
203
New research at Washington University School of Medicine in St. Louis helps illuminate a surprising mind-body connection. In mice, the researchers found that immune cells surrounding the brain produce a molecule that is then ...
Sep 14, 2020
0
701
Like so many other good things in life, sleep is best in moderation. A multiyear study of older adults found that both short and long sleepers experienced greater cognitive decline than people who slept a moderate amount, ...
Oct 20, 2021
0
182
People who received two doses of the Pfizer COVID-19 vaccine while on TNF inhibitors—a class of immunosuppressants used to treat rheumatoid arthritis and other autoimmune conditions—generated less powerful and shorter-lived ...
Nov 19, 2021
0
137
